rss
BMJ Case Reports 2012; doi:10.1136/bcr-2012-006858
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Photoactivated platelet-rich plasma therapy for a traumatic knee chondral lesion

  1. Andrew Rotstein3
  1. 1Lifecare Prahran Sports Medicine Centre, Melbourne, Victoria, Australia
  2. 2MetroSpinal Clinic, Melbourne, Victoria, Australia
  3. 3Victoria House Medical Imaging, Melbourne, Victoria, Australia
  1. Correspondence to Dr Julien Ben Freitag, julien.freitag{at}me.com

Summary

To evaluate the effect of combining photoactivation therapy with platelet-rich plasma injections in the treatment of a traumatic chondral lesion of the knee. A 38-year-old man presented with left-knee pain and swelling following a basketball injury. MRI demonstrated a full-thickness lateral tibial plateau chondral flap with subchondral cyst formation and marrow oedema. The patient underwent a course of photoactivated platelet-rich plasma (PAPRP) injections. Patient outcome measures included the numerical pain rating scale and the Western Ontario and McMaster Universities Arthritis Index 3.0 (WOMAC). Following treatment, the patient reported improvement in both pain and function as measured by the numerical pain-rating scale and WOMAC. MRI showed resolution of subchondral bone marrow bruising/oedema. No complications were noted. In this case report, PAPRP injections demonstrated improvement in all recorded outcome measures. Recognising the limitations of a single case report, the results highlight the need for more formal controlled trials to determine the potential use of PAPRP in the treatment of chondral lesions

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article